The global bile duct cancer market is estimated to be valued at US$ 185.4 million in 2021 and is expected to exhibit a CAGR of 12.8% over the forecast period (2021-2028).
Global Bile Duct Cancer Market: Drivers
Approval and launch of new products is expected to propel growth of the global bile duct cancer market over the forecast period. For instance, RenovoRx, in August 2020, received Orphan Drug Designation from the U.S. FDA for RenovoCath, an intra-arterial device of gemcitabine (Gemzar), for the treatment of patients with bile duct cancer market.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/4790
Moreover, high prevalence of bile duct cancer is expected to propel growth of the global bile duct cancer market over the forecast period. For instance, around 8,000 people in the U.S. were diagnosed with bile duct cancer in 2019, according to the American Society of Clinical Oncology (ASCO) report 2019. Age standardized incidence rate of bile duct cancer in Khon Kaen, Thailand, was around 84 per 100,000 in males and 36 per 100,000 in females, according to World Cholangiocarcinoma Day Statistics in 2016.
Major players operating in the global bile duct cancer market are focused on approval and launch of new drugs to expand their product portfolio. For instance, Incyte Corporation, in 2020, received Health Canada New Drug Submission approval for pemigatinib, a selective fibroblast growth factor receptor inhibitor, for the treatment of unresectable locally advanced or metastatic bile duct cancer with FGFR2 fusion or other rearrangement.
Global Bile Duct Cancer Market: Competitive Landscape
Major players operating in the global bile duct cancer market include, Ability Pharmaceuticals, Agios Pharmaceuticals, Inc., Delcath Systems, Inc., Eisai Co., Ltd., Imbrium Therapeutics L.P., Incyte Corporation, QED Therapeutics, Inc., and RenovoRx.
Global Bile Duct Cancer Market: Key Developments
Major players operating in the global bile duct cancer market are focused on adopting merger and acquisition strategies to expand their product portfolio. For instance, Servier, in January 2021, acquired Agios, Pharmaceuticals company’s commercial, clinical, and research-stage oncology portfolio which includes Tibsovo (ivosidenib tablets) for treatment of bile duct cancer and others.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/4790
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Bile Duct Cancer Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Bile Duct Cancer Industry Impact
Chapter 2 Global Bile Duct Cancer Competition by Types, Applications, and Top Regions and Countries
2.1 Global Bile Duct Cancer (Volume and Value) by Type
2.3 Global Bile Duct Cancer (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Bile Duct Cancer Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Bile Duct Cancer Market Analysis
Chapter 6 East Asia Bile Duct Cancer Market Analysis
Chapter 7 Europe Bile Duct Cancer Market Analysis
Chapter 8 South Asia Bile Duct Cancer Market Analysis
Chapter 9 Southeast Asia Bile Duct Cancer Market Analysis
Chapter 10 Middle East Bile Duct Cancer Market Analysis
Chapter 11 Africa Bile Duct Cancer Market Analysis
Chapter 12 Oceania Bile Duct Cancer Market Analysis
Chapter 13 South America Bile Duct Cancer Market Analysis
Chapter 14 Company Profiles and Key Figures in Bile Duct Cancer Business
Chapter 15 Global Bile Duct Cancer Market Forecast (2022-2028)
Chapter 16 Conclusions
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/4790
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027